住院患儿禁忌药物相互作用与相关不良反应的观察性队列研究
该研究在2年内前瞻性观察4543例住院患儿,使用法国ANSM官方DDI词典的Thériaque数据库算法识别禁忌性药物相互作用(DDI)。12.5%患儿经历至少一种DDI,4.3%存在至少一种禁忌性DDI;共识别4225种DDI,其中709种为禁忌性。结论认为禁忌性DDI很少与临床相关不良反应相关,提示需提高儿科住院DDI警示系统的特异性和临床相关性。
要点
- 住院患儿中12.5%发生至少一种DDI,4.3%存在至少一种禁忌性DDI。
- 72%的禁忌性DDI集中在小儿心内科、发育精神病理病房和肺/过敏/囊性纤维化病房。
- 80%的禁忌性DDI见于2-11岁和12-15岁患儿。
核心结论
- 住院儿科患者中检测到大量DDI,但禁忌性DDI很少与临床相关不良反应相关。
- 研究提示需提高儿科住院DDI警示系统的特异性和临床相关性。
研究设计与样本
- 前瞻性观察性队列研究,观察期2年,纳入4543例住院患儿。
- 纳入标准为年龄≤15岁、住院>3天且住院期间接受至少两种药物。
- 使用Thériaque数据库算法识别潜在禁忌性DDI,该算法基于法国ANSM官方DDI词典。
主要发现
- 12.5%的住院患儿经历至少一种DDI,4.3%存在至少一种禁忌性DDI。
- 共识别4225种DDI,其中709种被归类为禁忌性DDI。
- 72%的禁忌性DDI发生在小儿心内科、发育精神病理病房和肺/过敏/囊性纤维化病房。
- 80%的禁忌性DDI见于2-11岁和12-15岁患儿。
临床怎么用
- 临床药师在儿科住院患者中应关注禁忌性DDI,尤其在小儿心内科、发育精神病理病房和肺/过敏/囊性纤维化病房。
- 对2-11岁和12-15岁住院患儿应加强DDI筛查。
- 现有DDI警示系统在儿科住院环境中特异性不足,需结合临床相关性进行判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Drug-drug interactions (DDIs) are associated with an increased risk of adverse drug reactions (ADRs). Hospitalized children are particularly vulnerable to DDIs and ADRs due to polypharmacy, frequent use of unlicensed or off-label medications, and dosing regimens often extrapolated from adult data. The aims of this study were to characterize contraindicated DDIs detected in paediatric hospital wards and to assess whether these interactions were associated with ADRs. EXPERIMENTAL APPROACH: Medication and ADR data were prospectively collected over a 2-year observational period in hospitalized children. Patients aged ≤15 years, hospitalized for >3 days and receiving at least two medication during their stay were eligible. Potential contraindicated DDIs were identified using the algorithm implemented in the Thériaque database, based on the official DDI Thesaurus issued by the French National Agency for the Safety of Medicines and Health Products (ANSM). KEY RESULTS: A total of 4543 hospitalized children were included; 12.5% experienced at least one DDI, and 4.3% had at least one contraindicated DDI. Overall, 4225 DDIs were identified, including 709 classified as contraindicated. Thus 72% of the contraindicated DDIs occurred in three departments: paediatric cardiology, developmental psychopathology ward and pulmonology/allergology/cystic fibrosis. Most contraindicated DDIs (80%) were observed in children aged 2-11 years and 12-15 years. CONCLUSION AND IMPLICATIONS: Although a large number of DDIs were detected in hospitalized paediatric patients, contraindicated DDIs were rarely associated with clinically relevant ADRs. These findings highlight the need to improve the specificity and clinical relevance of DDI alert systems in paediatric inpatient settings.
引用
- Laval E, Goutelle S, Boussaha I, et al. Contraindicated drug-drug interactions and associated adverse drug reactions in an observational cohort study of 4543 paediatric hospitalized patients. Br J Clin Pharmacol. 2026. PMID: 42049472. doi:10.1002/bcp.70557
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。